---
$id: https://graph.org.ai/products/commodity/51334002
$type: Product
source: UNSPSC
code: "51334002"
title: "Spiramide"
class: "51334000"
classTitle: "Antipsychotic spiro compounds"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Spiramide

**UNSPSC Code**: 51334002
**Class**: [Antipsychotic spiro compounds](Antipsychotic spiro compounds.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antipsychotic agent with the molecular formula C22H26FN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 471LF4O004, chemically known as 1,3,8-triazaspiro(4.5)decan-4-one, 8-(3-(4-fluorophenoxy)propyl)-1-phenyl- but generally known as spiramide, which bears US NIH Compound Identifier 68186. European Medicines Agency schedules Spiramide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10619MIG. The term SPIRAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). SPIRAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule spiramide under HS 29333999 and SITC 51574. As of Q4 2014, SPIRAMIDE remains the US FDA Preferred Term for this commodity. Spiramide bears US NLM identifiers UMLS ID C0075006 and NCI Concept Code C66559. SMILES: FC1CCC(OCCCN2CCC3(N(CNC3=O)C3CCCCC3)CC2)CC1.

